These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12904099)

  • 1. The Cambridge Healthtech Institute's 9th Annual Conference on Blood Safety.
    Farrugia A
    Expert Opin Drug Saf; 2003 Jul; 2(4):431-5. PubMed ID: 12904099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cambridge Healthtech Institute's 2nd Annual Conference on Pharmacogenomics Europe: presaging profits.
    Kerb R; Brinkmann U
    Pharmacogenomics; 2001 Aug; 2(3):303-5. PubMed ID: 11939136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cambridge Healthtech Institute's 4th Annual Recombinant Antibodies Conference.
    Casey JL; Coley AM
    Expert Opin Biol Ther; 2003 Aug; 3(5):859-62. PubMed ID: 12880385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cambridge Healthtech Institute's Third Annual Conference on Lab-on-a-Chip and Microarrays. 22-24 January 2001, Zurich, Switzerland.
    Jain KK
    Pharmacogenomics; 2001 Feb; 2(1):73-7. PubMed ID: 11258200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes and the heart: a quest for new therapeutic strategies. Cambridge Healthtech Institute's First Cardiovascular Genomics Conference. Orlando, FL, USA, 11-12 January 1999.
    Durham NP; Hall AS
    Mol Med Today; 1999 May; 5(5):195-7. PubMed ID: 10454840
    [No Abstract]   [Full Text] [Related]  

  • 6. The Future of Cancer Diagnostics: Next Generation Molecular Technologies - Cambridge Healthtech Institute's Inaugural Conference.
    Martin FL
    IDrugs; 2008 Nov; 11(11):787-90. PubMed ID: 18988119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the genome: turning data into knowledge.
    Milburn J
    Drug Discov Today; 2001 Sep; 6(17):881-883. PubMed ID: 11522515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cambridge Healthtech Institute's 7th Annual, identifying and validating metabolic markers for drug development and clinical studies.
    Beger RD
    Expert Rev Mol Diagn; 2007 Mar; 7(2):113-5. PubMed ID: 17331060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transfusion risks: importance of blood surveillance].
    Salamon R; Lawson-Ayayi S; Salmi LR
    Transfus Clin Biol; 1994; 1(5):373-8. PubMed ID: 7812464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cambridge Healthtech Institute's 3rd Annual Laser Capture Microscopy: cutting edge applications. May 2-3 2005, World Trade Center, Boston, MA, USA.
    Bhattacherjee V; Greene R; Pisano MM
    Expert Rev Mol Diagn; 2005 Jul; 5(4):487-91. PubMed ID: 16013966
    [No Abstract]   [Full Text] [Related]  

  • 11. Cambridge Healthtech Institute's 2007 Biomarker Discovery Summit.
    Luke BT
    Expert Rev Mol Diagn; 2007 Nov; 7(6):755-7. PubMed ID: 18020904
    [No Abstract]   [Full Text] [Related]  

  • 12. Cambridge Healthtech Institute's 5th Annual 'Molecular Display: The Chemistry Set for Proteins and Small Molecules' Conference.
    Coley AM; Casey JL
    Expert Opin Biol Ther; 2003 Aug; 3(5):855-8. PubMed ID: 12880384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of blood donations for HTLV-I/II.
    Couroucé AM; Pillonel J; Saura C
    Transfus Med Rev; 1999 Oct; 13(4):267-74. PubMed ID: 10553270
    [No Abstract]   [Full Text] [Related]  

  • 14. Acres of antibodies: the future of recombinant biomolecule production?
    Sayers JR
    Trends Biotechnol; 2001 Nov; 19(11):429-30. PubMed ID: 11602287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of predonation screening for transfusion transmissible infections using rapid test kits in a hospital-based blood transfusion centre.
    Dosunmu AO; Akinbami AA; Ismail AK; Olaiya MA; Uche EI; Aile IK
    Niger Postgrad Med J; 2017; 24(3):162-167. PubMed ID: 29082905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Injury to blood donor by blood transfusion; contribution to the blood donor service].
    GAERTNER W
    Zentralbl Chir; 1953; 78(2):68-70. PubMed ID: 13050072
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there a limit to the normality of blood products?
    Degos L
    Hematol J; 2000; 1(5):291. PubMed ID: 11920204
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood product-associated bacterial sepsis.
    Goldman M; Blajchman MA
    Transfus Med Rev; 1991 Jan; 5(1):73-83. PubMed ID: 1802278
    [No Abstract]   [Full Text] [Related]  

  • 19. All aboard the chip!
    Leung YF; Pang CP
    Trends Biotechnol; 2001 Nov; 19(11):430-1. PubMed ID: 11602288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings of a consensus conference: Risk-Based Decision Making for Blood Safety.
    Leach Bennett J; Blajchman MA; Delage G; Fearon M; Devine D
    Transfus Med Rev; 2011 Oct; 25(4):267-92. PubMed ID: 21763103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.